Therapeutic areas with analogue competition


When several pharmaceuticals with the same clinical effect are made available on the market, analogue competition is possible. This takes place when the Danish Medicines Council prepares treatment guidelines and cost analyses and Amgros conducts tendering procedures.

Click here to read more about our tendering procedures

When several pharmaceuticals with a uniform clinical effect become available on the market, there is the possibility of analogous competitive exposure. This is done based on treatment guidelines from RADS (The former Danish Council for the Use of Expensive Hospital Medicines) and the Danish Medicines Council.

Based on the Danish Medicines Council treatment guidelines and the cost analyses, Amgros prepares and implements tenders. The Danish Medicines Council uses the result of the tender to prepare a recommendation. An extended comparison has not been prepared in RADS’ treatment guidelines.

Read more about the tendering process here.

The recommendation is published on website of the Danish Medicines Council.


The process

We have drawn up a figure that shows the process for therapeutic areas.

 

See figure

Photographer: Anne-Li Engström

READ MORE

Therapeutic areas with analogue competition

Price negotiations and tendering

Amgros manages procurement of almost all the medicine used in Danish public hospitals. It is our task to organise tendering procedures for pharmaceuticals so that we cover hospital needs

READ MORE
Therapeutic areas with analogue competition

Pharmaceuticals

Danes are living longer. And we can treat more diseases, because new and better drugs are entering the market all the time. This is good. But it’s expensive. Therefore, it is important that we are at the forefront of market developments.

READ MORE
Therapeutic areas with analogue competition

Efficient changes of medicines

Amgros works closely with the regions - hospital pharmacies, pharmaceutical committees and clinical pharmacologists - to ensure that new medicines get into use rapidly as standard treatment at hospitals - and thereby get to patients quickly too. Together, we also ensure that the regions can reap the savings as soon as possible because the medicine will have been through our national tendering procedure.

READ MORE

Trine Maria Roed

Team Lead

I'm responsible for managing and ensuring priorities so that we align tendering procedures in collaboration with the Danish Medicines Council. The team are the drivers of tenders for medicines included in processes at the Danish Medicines Council.